trans,trans-4-(3,4-Difluorophenyl)-4'-pentyl-1,1'-bi(cyclohexane), 97%, 10g

methyl 4-(3-hydroxyphenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95.0%, 1g

4-Bromo-5-chloropyridin-2-amine, 98.0%, 100g

N,N'-Disuccinimidyl carbonate, 95.0%, 25g

2-Cyclopropylpyridine, 95%, 1g

5-Phenyl-1H-1,2,4-triazol-3-amine>98.0%(GC)(T)1g

(8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate, 95.0%, 100mg

Ethyl 5-bromo-2-chloronicotinate, 95+%, 250mg

Estándar de viscosidad N15000, ROTI®Calipure, 77000 cSt (20 °C), 500 ml, envase de vidrio

4-(2-Amino-ethoxymethyl)-piperidine-1-carboxylic acid tert-butyl ester, 250mg

1-(4-Aminopiperidin-1-yl)-3-methylbutan-1-one hydrochloride, 95.0%, 25g

2-(2,5-Difluorophenyl)ethanol, 97%, 2.5g

Cyclo(-L-Leu-L-Phe), 98.0%, 250mg